How Great Point Partners' Exit from Valenz® Health Points to Promising Healthcare Industry Growth
Gracie Gottlieb | 21 June, 2023
Great Point Partners announced its exit from Valenz® Health, a healthcare industry private investment firm, after a six-year partnership. Kelso & Company made the acquisition after Valenz's revenue grew by close to 30% per year during their partnership. Great Point Partners' broad network of advisors fostered through past investments in the payment integrity field transformed Valenz's business through strategic M&A, expanding its distribution channel, and increasing its existing market penetration. The growth of the healthcare industry looks promising as healthcare providers like Valenz continue to expand and grow.
The Healthcare Industry is Growing
The healthcare industry is rapidly expanding, and it's no secret why. With advancements in medicine and technology, healthcare providers have the ability to offer better and more accessible healthcare to patients. Growth in the industry means more innovation, better care, and increased access.
Valenz's Growth
Valenz Health's expansion is a testament to the healthcare industry's growth and innovation. Since partnering with Great Point Partners in 2017, Valenz's enterprise value grew over 700%, and it completed eight strategic acquisitions that helped grow its revenue by more than 500%. These acquisitions were primarily sourced by Great Point Partners, demonstrating the firm's ability to leverage its vast network of advisors.
The strategic acquisitions helped Valenz establish an experienced board of directors in the payment integrity space, expand its distribution channel, and increase its existing market penetration. These strategic business moves helped Valenz address many key market challenges in the self-insured industry, including the lack of transparency within medical costs and wide variances in reimbursement rates.
Great Point Partners' Role in Valenz's Growth
Great Point Partners' exit from Valenz Health after six years is a significant milestone for the healthcare industry, indicating potential growth within the payment integrity sector. Great Point Partners' expertise in the payment integrity space and track record of investment success with founder-owned businesses were crucial factors in Valenz's success.
Great Point Partners' ability to support Valenz's strategic business moves led to the growth of its revenue by over 500%. Great Point Partners was instrumental in expanding Valenz's distribution channel and increasing its existing market penetration, helping the company address many of the self-insured industry's key market challenges.
Final Thoughts
Great Point Partners' exit from Valenz Health is a representation of the healthcare industry's growth and the potential for more significant expansion. With advancements in medical and technology, healthcare providers like Valenz have the ability to offer better and more accessible healthcare to patients. Great Point Partners' ability to leverage its vast network of advisors and support Valenz's strategic business moves led to the company's growth by over 500%. As Valenz continues to grow under Kelso & Company's ownership, the healthcare industry continues to look promising as a space for innovation and growth.
Other Posts
- EverService: Empowering Growth and Expansion in Tech-Enabled Business Solutions
- Investment Giant Oldfield Partners LLP Q3 vs. Q4 2022: A Comprehensive Analysis
- EisnerAmper Wealth Management Corporate Benefits, LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Navigating the Investment Landscape: A Deep Dive into Q4 2023 vs. Q1 2024 Fund Holdings Shifts
- Wealth Alliance Advisory Group, LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Symmetry Partners' Top Q1 2023 Holdings: What You Need to Know
- Simon Quick Advisors, LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Maple Capital Management, Inc. Q3 to Q4 2022 13F Comparison: Apple and Alphabet Inc. among Top Holdings that Experienced Steep Drops in Value.
- Options Technology Achieves Ultra-Low Latency Milestone with Full Deployment of JPX Layer 1 Offering
- An Analysis of Silver Point Capital L.P.'s Q3 2022 vs. Q4 2022 13F Holdings